1L30 Stock Overview
Lifco AB (publ) engages in the dental, demolition and tools, and systems solutions businesses in Sweden, Norway, Germany, rest of Europe, the United Kingdom, Asia, Australia, Italy, North America, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
1L30 passed our risk checks.
Lifco AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr22.84 |
| 52 Week High | kr25.63 |
| 52 Week Low | kr15.23 |
| Beta | 1.38 |
| 1 Month Change | -7.15% |
| 3 Month Change | 1.02% |
| 1 Year Change | 11.47% |
| 3 Year Change | 30.81% |
| 5 Year Change | 177.72% |
| Change since IPO | 764.63% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1L30 | DE Industrials | DE Market | |
|---|---|---|---|
| 7D | -0.3% | 0.9% | -0.5% |
| 1Y | 11.5% | 17.7% | 2.5% |
Return vs Industry: 1L30 underperformed the German Industrials industry which returned 17.3% over the past year.
Return vs Market: 1L30 exceeded the German Market which returned 1.8% over the past year.
Price Volatility
| 1L30 volatility | |
|---|---|
| 1L30 Average Weekly Movement | 3.0% |
| Industrials Industry Average Movement | 4.3% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 1L30 has not had significant price volatility in the past 3 months.
Volatility Over Time: 1L30's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 6,887 | Per Waldemarson | www.lifco.se |
Lifco AB (publ) engages in the dental, demolition and tools, and systems solutions businesses in Sweden, Norway, Germany, rest of Europe, the United Kingdom, Asia, Australia, Italy, North America, and internationally. It is involved in the distribution of dental equipment, such as denture attachments, disinfectants, saliva ejectors, bite registration and dental impression materials, bonding agents, and other consumables, as well as develops and sells medical record systems. The company also operates dental laboratory.
Lifco AB (publ) Fundamentals Summary
| 1L30 fundamental statistics | |
|---|---|
| Market cap | €10.37b |
| Earnings (TTM) | €273.04m |
| Revenue (TTM) | €2.10b |
38.0x
P/E Ratio4.9x
P/S RatioIs 1L30 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1L30 income statement (TTM) | |
|---|---|
| Revenue | kr24.50b |
| Cost of Revenue | kr13.63b |
| Gross Profit | kr10.87b |
| Other Expenses | kr7.69b |
| Earnings | kr3.18b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 12, 2024
| Earnings per share (EPS) | 7.00 |
| Gross Margin | 44.37% |
| Net Profit Margin | 12.98% |
| Debt/Equity Ratio | 47.9% |
How did 1L30 perform over the long term?
See historical performance and comparison